Project
Oceanic AF
Completed - recruitment closed ยท 2023 until 2024
Rickli Hans, Fink Karin, Vetsch Susanne
Type
Range
Units
Status
Start Date
End Date
Financing
Phase
Brief description/objective
A multicenter, international, randomized, active comparator-controlled, double-blind, doubledummy, parallel-group, 2-arm, Phase 3 study to compare the efficacy and safety of the oral FXIa inhibitor asundexian (BAY 2433334) with apixaban for the prevention of stroke or systemic embolism in male and female participants aged 18 years and older with atrial fibrillation at risk for stroke